U.S. stock market midday update: GRML down 12.78% on increased volume, no negative news but funds are fleeing?Price Alert·1 hour agoGRML-14.36%
Weekly Recap | Ark Innovation ETF +6.3%, crypto and biotech lead the chargeWeekly Review·2 days ago, 01:16 AMARKK-1.82%
Weekly Recap | Sutro Biopharma +2.73%, consensus target well above spotWeekly Review·2 days ago, 12:44 AMSTRO-2.08%
Weekly Recap | United Therap +2.68%, most brokers rate it buyWeekly Review·2 days ago, 12:44 AMUTHR-0.05%
Weekly Recap | ImmunityBio this week, a quiet, low-volume weekWeekly Review·2 days ago, 12:07 AMIBRX-2.12%
Weekly Recap | CRISPR Therap +11.11%, consensus target above spotWeekly Review·2 days ago, 11:51 PMCRSP-4.02%
Weekly Recap | BioNTech SE +25.22%, mRNA cancer vaccine breakthrough lifts sectorWeekly Review·2 days ago, 11:40 PMBNTX-4.35%
U.S. stock market midday update: INDP down 10.14% with no significant negative news, capital movement causing fluctuationsPrice Alert·2 days ago, 12:58 PMINDP-10.85%
U.S. Stock Market Midday Update: AARD up 12.22%! IPO misleading allegations lead to class action lawsuit, legal risks intensify market volatilityPrice Alert·Aug 21 at 11:48 AMAARD-0.73%
19:31 ETMAHA ACTION WELCOMES BIOTECH PIONEER LOU REESE TO ITS BOARD OF DIRECTORSprnewswire·Apr 21 at 06:33 PMVAXX+100.00%BBH-0.82%
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release | VEXTF Stock NewsStockTitan·Apr 21 at 07:35 AMVTYX0.00%VAXX+100.00%
European Union funds SK-IIDT-Vaxxas consortium for high-density microarray patch vaccines to enhance seasonal & pandemic flu protection.Unusual Whales·Feb 26 at 07:01 AMASMB+3.50%IHE-0.07%
